Browsing: Novo Nordisk

MENA Newswire,  NEW YORK: Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available in an oral pill form in the United States, marking a major…

Uninsured Americans can now access Ozempic for $499 monthly as Novo Nordisk rolls out a direct-to-consumer model through telehealth providers.

Novo Nordisk shares dropped 20% after cutting full-year guidance and naming a new CEO, citing U.S. market weakness for Wegovy and Ozempic.

Novo Nordisk’s amycretin shows up to 22% weight loss in trials, boosting its stock by 6.87% as the drug exhibits safety and potential as a next-gen obesity treatment.

A peer-reviewed study released on Monday reveals that an oral weight loss drug developed by Pfizer demonstrates similar efficacy and…